Showing 1672 results
-
Media Library / -
Story /Novartis team perseveres to develop more personalized approach to breast cancer therapy.
-
Press release /Patients on Tasigna achieved rapid and high rates of molecular response with a very low rate of progression to advanced disease ENEST1st data confirm the favorable benefit/risk profile of…
-
Ad hoc release /Ad hoc announcement pursuant to Art. 53 LR Q1 sales grew +5% (cc1, +1% USD), core operating income grew +9% (cc, +3% USD) Innovative Medicines (IM) sales grew +4% (cc, +1% USD) and core…
-
Featured News /Novartis included in Dow Jones Sustainability World Index, with industry-leading performance in environmental and social reporting and human capital.
-
In The News /In this Bloomberg interview, Vas Narasimhan, CEO of Novartis shares his thoughts on how medicines can have a transformative effect.